Mangalam Drugs and Organics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mangalam Drugs and Organics Ltd. on BSE

Load latest

Mangalam Drugs and Organics Ltd.

27 Sep 2024

70.73

-2.28%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 pursuant to Re-appointment of Shri Govardhan M DHoot as Managing DIrector for a term of 3 years and Re-appointmnet of SHri Brijmohan M Dhoot as a whole time Director of the Company for a period of Three years.

pdf

Mangalam Drugs and Organics Ltd.

26 Sep 2024

70.73

-2.28%

AGM

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Proceedings of 51st Annual General Meeting conducted through Video Conferencing and other Audio Visual Means in compliance with Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 taking in record the five agenda items. Kindly acknowledge.

pdf

Mangalam Drugs and Organics Ltd.

06 Sep 2024, 10:09AM

70.73

-2.28%

SAST

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 05, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd

pdf

Mangalam Drugs and Organics Ltd.

05 Sep 2024

70.73

-2.28%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Notice of 51st Annual General Meeting of the Company to be held on Thursday, 26th September, 2024 has been published in English Newspaper- Financial Express and Marathi Newspaper- Loksatta on 5th of September, 2024.

pdf

Mangalam Drugs and Organics Ltd.

04 Sep 2024

70.73

-2.28%

Corp. Note

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Reg. 34 (1) Annual Report.

BSE India

We wish to inform you that 51st AGM of the Company is scheduled to be held on Thursday, September 26, 2024 at 3:00 P.M. through video conference or other audio visual means, in accordance with the relevant circulars issued by Ministry of Corporate Affairs and SEBI Please find enclosed Annual Report of the Company for the Financial Year 2023-24 including Notice convening the 51st AGM

pdf

Mangalam Drugs and Organics Ltd.

04 Sep 2024

70.73

-2.28%

AGM

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Notice Of 51St Annual General Meeting (AGM) Of …

BSE India

We wish to inform you that 51st AGM of the Company is scheduled to be held on Thursday September 26th, 2024 at 3:00 P.M. through video conference or other audio visual means, in accordance with the relevant circulars issued by Ministry of Corporate Affairs and SEBI. Please find enclosed Annual report of the Company for the financial year 2023-24 including Notice convening the 52st AGM

pdf

Mangalam Drugs and Organics Ltd.

27 Aug 2024

70.73

-2.28%

SAST

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 26, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd

pdf

Mangalam Drugs and Organics Ltd.

26 Aug 2024

70.73

-2.28%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Intimation As Per Regulation 30 Of SEBI (Listing …

BSE India

Intimation for getting grant from MMV for research and development of Pyronaridine.

pdf

Mangalam Drugs and Organics Ltd.

20 Aug 2024

70.73

-2.28%

Corp. Note

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosure under Regulation 30A of LODR

BSE India

Intimation under regulation 30 of (Securities and Disclosure Requirements) Regulations, 2015 regarding Introduction of Pyronaridine having recently received prestigious pre qualification from WHO Geneva.

pdf

Mangalam Drugs and Organics Ltd.

14 Aug 2024

70.73

-2.28%

Company Update

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Approval of Un-audited Financial Results of the Company for the quarter ended 30.06.2024

pdf

Is Mangalam Drugs and Organics Ltd. worth buying?

99 Votes:

Buy 78.79%

Sell 15.15%

Hold 6.06%